Skip to main content

Mijn bibliotheek

Shop

Nieuws
Boeken
Tijdschriften
E-learning
Web-tv
Video
Audio

Tips voor Mijn BSL

UITGEBREID ZOEKEN
Inloggen
Top
Journal of Autism and Developmental Disorders

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Journal of Autism and Developmental Disorders 4/2016

11-01-2016 | Original Paper

Assessment of Cognitive Outcome Measures in Teenagers with 15q13.3 Microdeletion Syndrome

Auteurs: Emeline Crutcher, May Ali, John Harrison, Judit Sovago, Baltazar Gomez-Mancilla, Christian P. Schaaf

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 4/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

15q13.3 microdeletion syndrome causes a spectrum of cognitive disorders, including intellectual disability and autism. We aimed to determine if any or all of three cognitive testing systems (the KiTAP, CogState, and Stanford–Binet) are suitable for assessment of cognitive function in affected individuals. These three tests were administered to ten individuals with 15q13.3 microdeletion syndrome (14–18 years of age), and the results were analyzed to determine feasibility of use, potential for improvement, and internal consistency. It was determined that the KiTAP, CogState, and Stanford–Binet are valid tests of cognitive function in 15q13.3 microdeletion patients. Therefore, these tests may be considered for use as objective outcome measures in future clinical trials, assessing change in cognitive function over a period of pharmacological treatment.
vorige artikel Emergency Department Use Among Adults with Autism Spectrum Disorders (ASD)
volgende artikel Brief Report: Scurvy as a Manifestation of Food Selectivity in Children with Autism
Literatuur
Aman, M. G., Novotny, S., Samango-Sprouse, C., Lecavalier, L., Leonard, E., Gadow, K. D., et al. (2004). Outcome measures for clinical drug trials in autism. CNS Spectrums, 9(1), 36–47. PubMedPubMedCentral
Freedman, R. (2014). α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annual Review of Medicine, 65(September 2013), 245–261. CrossRefPubMed
Grondhuis, S., & Mulick, J. (2013). Comparison of the Leiter International Performance Scale-Revised and the Stanford–Binet Intelligence Scales, 5th Edition, in children with autism spectrum disorders. American Journal on Intellectual and Developmental Disabilities, 118(1), 44–54. CrossRefPubMed
Hellwig-Brida, S., Daseking, M., Keller, F., Petermann, F., & Goldbeck, L. (2011). Effects of methylphenidate on intelligence and attention components in boys with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21(3), 245–253. CrossRefPubMed
Jucaite, A., Öhd, J., Potter, A. S., Jaeger, J., Karlsson, P., Hannesdottir, K., et al. (2014). A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Psychopharmacology, 231(6), 1251–1265. CrossRefPubMedPubMedCentral
Kaufmann, L., Zieren, N., Zotter, S., Karall, D., Scholl-Bürgi, S., Haberlandt, E., et al. (2010). Predictive validity of attentional functions in differentiating children with and without ADHD: A componential analysis. Developmental Medicine and Child Neurology, 52(4), 371–378. CrossRefPubMed
Knox, A., Schneider, A., Abucayan, F., Hervey, C., Tran, C., Hessl, D., et al. (2012). Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS). Journal of Neurodevelopmental Disorders, 4(1), 2. doi: 10.​1186/​1866-1955-4-2. CrossRefPubMedPubMedCentral
Lowther, C., Costain, G., Stavropoulos, D. J., Melvin, R., Silversides, C. K., Andrade, D. M., et al. (2014). Delineating the 15q13.3 microdeletion phenotype: A case series and comprehensive review of the literature. Genetics in Medicine, 17(2), 149–157. CrossRefPubMedPubMedCentral
Mollica, C. M., Maruff, P., & Vance, A. (2004). Development of a statistical approach to classifying treatment response in individual children with ADHD. Human Psychopharmacology, 19(7), 445–456. CrossRefPubMed
Ozonoff, S., Goodlin-Jones, B. L., & Solomon, M. (2005). Evidence-based assessment of autism spectrum disorders in children and adolescents. Journal of Clinical Child and Adolescent Psychology, 34(3), 523–540. CrossRefPubMed
Rothmann, K., Hillmer, J., & Hosser, D. (2014). Evaluation of the Musical Concentration Training with Pepe (MusiKo mit Pepe) for children with attention deficits. Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie, 42(5), 325–335. CrossRefPubMed
Sandler, A. (2005). Placebo effects in developmental disabilities: Implications for research and practice. Mental Retardation and Developmental Disabilities Research Reviews, 11(2), 164–170. CrossRefPubMed
Schaaf, C. P. (2014). Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 16(9), 649–656. CrossRefPubMed
Silverman, W., Miezejeski, C., Ryan, R., Zigman, W., Krinsky-McHale, S., & Urv, T. (2010). Stanford–Binet and WAIS IQ differences and their implications for adults with intellectual disability (aka mental retardation). Intelligence, 38(2), 242–248. CrossRefPubMedPubMedCentral
Tropeano, M., Andrieux, J., Vassos, E., & Collier, D. A. (2014). Clinical utility gene card for: 15q13.3 microdeletion syndrome. European Journal of Human Genetics, 22(11), 1338. CrossRefPubMedCentral
Yamashita, Y., Mukasa, A., Anai, C., Honda, Y., Kunisaki, C., Koutaki, J., et al. (2011). Summer treatment program for children with attention deficit hyperactivity disorder: Japanese experience in 5 years. Brain and Development, 33(3), 260–267. CrossRefPubMed
Metagegevens
Titel
Assessment of Cognitive Outcome Measures in Teenagers with 15q13.3 Microdeletion Syndrome
Auteurs
Emeline Crutcher
May Ali
John Harrison
Judit Sovago
Baltazar Gomez-Mancilla
Christian P. Schaaf
Publicatiedatum
11-01-2016
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 4/2016
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-015-2694-0

Andere artikelen Uitgave 4/2016

Journal of Autism and Developmental Disorders 4/2016 Naar de uitgave

Original Paper

Distinctive Role of Symbolic Number Sense in Mediating the Mathematical Abilities of Children with Autism

Original Paper

Bimodal Virtual Reality Stroop for Assessing Distractor Inhibition in Autism Spectrum Disorders

Book Review

W. Solomon, C. Holland, M. J. Middleton: Autism and Understanding: The Waldon Approach to Child Development

Original Paper

Age-Related Differences in Response to Music-Evoked Emotion Among Children and Adolescents with Autism Spectrum Disorders

Original Paper

Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum

Original Paper

Are Children with Autism Spectrum Disorder Initially Attuned to Object Function Rather Than Shape for Word Learning?